Oruka Therapeutics (ORKA) Total Current Liabilities (2010 - 2026)
Oruka Therapeutics' quarterly Total Current Liabilities came in at $16.6 million in Q1 2026, up 41.88% year-on-year from $11.7 million in Q1 2025, and up 8.19% quarter-over-quarter from $15.4 million in Q4 2025.
Oruka Therapeutics has reported Total Current Liabilities for 17 years, with the latest figure at $16.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 41.88% year-over-year to $16.6 million; the trailing twelve-month figure through Mar 2026 stood at $16.6 million (up 41.88% YoY), and the FY2025 full-year result was $15.4 million, up 17.87% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $16.6 million, up from $15.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $21.0 million in Q3 2025, with the low at $637000.0 in Q4 2023.
- Average Total Current Liabilities over 5 years is $7.3 million, with a median of $2.7 million recorded in 2022.
- Year-over-year, Total Current Liabilities plunged 67.64% in 2022 and surged 1947.57% in 2024.
- Tracing ORKA's Total Current Liabilities over 5 years: stood at $1.1 million in 2022, then plunged by 43.73% to $637000.0 in 2023, then surged by 1947.57% to $13.0 million in 2024, then rose by 17.87% to $15.4 million in 2025, then increased by 8.19% to $16.6 million in 2026.
- The last three Total Current Liabilities figures came in at $16.6 million (Q1 2026), $15.4 million (Q4 2025), and $21.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 16.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.63 Mn |
| Dec 31, 2025 | 15.37 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Jun 30, 2025 | 12.11 Mn |
| Mar 31, 2025 | 11.72 Mn |
| Dec 31, 2024 | 13.04 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 637,000.00 |
| Sep 30, 2023 | 992,000.00 |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.94 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Sep 30, 2021 | 3.18 Mn |
| Jun 30, 2021 | 3.70 Mn |
| Mar 31, 2021 | 2.88 Mn |
| Dec 31, 2020 | 3.50 Mn |
| Sep 30, 2020 | 1.53 Mn |
| Jun 30, 2020 | 1.33 Mn |
| Mar 31, 2020 | 1.16 Mn |
| Dec 31, 2019 | 926,000.00 |
| Sep 30, 2019 | 1.15 Mn |
| Jun 30, 2019 | 1.20 Mn |
| Mar 31, 2019 | 1.29 Mn |
| Dec 31, 2018 | 793,000.00 |
| Sep 30, 2018 | 978,000.00 |
| Jun 30, 2018 | 1.06 Mn |
| Mar 31, 2018 | 1.72 Mn |
| Dec 31, 2017 | 2.07 Mn |
| Sep 30, 2017 | 2.54 Mn |
| Jun 30, 2017 | 2.52 Mn |
| Mar 31, 2017 | 2.52 Mn |
| Dec 31, 2016 | 2.40 Mn |
| Sep 30, 2016 | 2.16 Mn |
| Jun 30, 2016 | 1.70 Mn |
| Mar 31, 2016 | 2.34 Mn |
| Dec 31, 2015 | 1.50 Mn |
| Sep 30, 2015 | 1.30 Mn |
| Jun 30, 2015 | 1.36 Mn |
| Mar 31, 2015 | 1.13 Mn |
| Dec 31, 2014 | 1.39 Mn |
| Sep 30, 2014 | 838,000.00 |
| Jun 30, 2014 | 1.22 Mn |
| Mar 31, 2014 | 1.12 Mn |
| Dec 31, 2013 | 1.50 Mn |
| Sep 30, 2013 | 769,000.00 |
| Jun 30, 2013 | 750,000.00 |
| Mar 31, 2013 | 828,000.00 |
| Dec 31, 2012 | 305,000.00 |
| Sep 30, 2012 | 286,000.00 |
| Jun 30, 2012 | 529,000.00 |
| Mar 31, 2012 | 594,000.00 |
| Dec 31, 2011 | 754,000.00 |
| Sep 30, 2011 | 661,000.00 |
| Jun 30, 2011 | 1.00 Mn |
| Dec 31, 2010 | 1.19 Mn |